Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:February 12, 2016Terminated
Hide Studies Not Open or Pending
Condition(s):Bladder CancerLast Updated:February 12, 2016Terminated
Condition(s):Urothelial Carcinoma; Bladder Cancer; Urothelial Neoplasm; Urothelial Carcinoma Bladder; Urothelial Carcinoma in SituLast Updated:May 9, 2022Recruiting
Condition(s):Bladder CancerLast Updated:July 28, 2023Recruiting
Condition(s):Bladder CancerLast Updated:May 31, 2023Completed
Condition(s):Postoperative Pain Management; Radical Cystectomy; Epidural Analgesia; Oral Oxycodone With/Without Naloxone; Return of the Bowel FunctionLast Updated:March 7, 2017Completed
Condition(s):Radical Cystectomy; Muscle-Invasive Bladder Carcinoma; Multiparametric MRI; Vesical Imaging Report and Data SystemLast Updated:October 28, 2021Active, not recruiting
Condition(s):Bladder Cancer; Carcinoma, Transitional CellLast Updated:September 27, 2006Unknown status
Condition(s):Bladder Cancer; Radical CystectomyLast Updated:November 29, 2023Recruiting
Condition(s):High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma; Perfusion; Complications; Intraoperative ComplicationsLast Updated:September 16, 2022Recruiting
Condition(s):Bladder Cancer; Cancer of the Bladder, Recurrent; Non-muscle Invasive Bladder CancerLast Updated:January 5, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.